X linked agammaglobulinaemia and rheumatoid arthritis. 2005

G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
Department of Rheumatology, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium.

BACKGROUND Much interest has been shown recently in the pathogenic role of B cells in rheumatoid arthritis (RA) owing to the marked clinical responses to anti-CD20 treatment in RA. METHODS A patient with X linked agammaglobulinaemia (XLA) presented with an erosive symmetric polyarthritis with histological features of RA, including formation of a destructive pannus. Furthermore, the patient developed subcutaneous nodules that were histologically indistinguishable from rheumatoid nodules. Surprisingly, lymphocytic infiltrates in both the synovium and nodule consisted almost exclusively of CD8+ T cells. CONCLUSIONS Although some peculiar B cell subsets have been described in patients with XLA, no B cell subsets could be demonstrated in synovial tissue or the subcutaneous nodule. This case illustrates that classical RA can develop in the absence of mature B cells.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D006225 Hand The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb. Hands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000361 Agammaglobulinemia An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood. Hypogammaglobulinemia,Agammaglobulinemias,Hypogammaglobulinemias
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D016131 Lymphocyte Subsets A classification of lymphocytes based on structurally or functionally different populations of cells. Lymphocyte Subpopulations,Lymphocyte Subpopulation,Lymphocyte Subset,Subpopulation, Lymphocyte,Subpopulations, Lymphocyte,Subset, Lymphocyte,Subsets, Lymphocyte
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
December 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
March 1960, Canadian Medical Association journal,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
April 1960, Canadian Medical Association journal,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
January 1960, Canadian Medical Association journal,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
March 2008, Clinical and experimental dermatology,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
January 1981, Acta neuropathologica. Supplementum,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
May 1993, Lancet (London, England),
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
January 2010, Allergologia et immunopathologia,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
May 1991, Journal of clinical pathology,
G Verbruggen, and S De Backer, and D Deforce, and P Demetter, and C Cuvelier, and E Veys, and D Elewaut
January 1988, European journal of pediatrics,
Copied contents to your clipboard!